Cancer Rates by Country 2025
Cancer continues to be one of the world's biggest health challenges, but the numbers tell a fascinating story when you look at how rates vary across different countries. Some nations report cancer rates that are nearly ten times higher than others. Let's dive into what the 2025 projections reveal about cancer around the world.
The Countries with the Highest Cancer Rates
If you're looking at where cancer rates are highest, you'll find some surprising patterns. Australia tops the list with an age-standardized rate (ASR) of 482.4 cases per 100,000 people. That means if you live in Australia, the statistical likelihood of encountering cancer is higher than almost anywhere else on Earth. The country is expecting around 228,202 new cancer cases in 2025.
Right behind Australia is New Zealand with an ASR of 431.1, showing a similar pattern to its neighbor. Together, these two countries in Oceania have the highest cancer rates globally, and it's not just because they have great healthcare systems that catch more cases – though that certainly plays a role.
Europe dominates the top spots too. Denmark (385.7), the United States (381.1), and Norway (379.8) round out the top five. In fact, if you scan through the data, you'll notice that European countries consistently show high rates. The Netherlands (351.0), France (353.4), and Ireland (363.3) all feature prominently in the upper brackets.
Here's the thing about these high-rate countries: they're mostly wealthy nations with aging populations and excellent healthcare systems. When you live longer, you're more likely to develop cancer. Plus, these countries have sophisticated screening programs that catch cancers early, which means more cases get recorded in their statistics. The UK reports 320.1 cases per 100,000 people with nearly 472,000 total cases expected in 2025. Germany isn't far behind with 283.7 ASR and a whopping 622,649 cases – one of the highest absolute numbers globally. On the opposite end of the spectrum, Sierra Leone has the world's lowest cancer rate at just 38.3 per 100,000 people. That's more than twelve times lower than Australia's rate. Other African nations like The Gambia (77.7), Yemen (80.1), and Nepal (82.4) also show remarkably low rates. But here's where it gets complicated: these low numbers don't necessarily mean people in these countries are healthier. Younger populations, shorter life expectancies, and less developed cancer detection systems all contribute to lower reported rates. It's a mix of different factors, not just one simple explanation. Asia shows a fascinating divide. Developed Asian economies like Japan (281.8) and South Korea (256.0) have rates comparable to European countries. Meanwhile, India sits at just 103.3, and Pakistan at 101.4 – despite both having massive populations (India expects over 1.5 million cases in 2025 just due to its enormous population). China presents an interesting case with an ASR of 207.6 and a projected 5.1 million cases – the highest absolute number in the world. But when you adjust for its huge population, the per-capita rate isn't as dramatic as Western nations. Turkey falls in the middle-upper range with an ASR of 232.7, expecting around 250,486 cases in 2025. That's a 4.4% increase from 2022's 240,013 cases. The country's cancer rate has been climbing faster than its population growth, which is a trend worth watching. Latin American countries cluster in the mid-range. Uruguay leads the region with 289.4, while Argentina (226.7) and Brazil (222.0) follow. Brazil's absolute numbers are staggering – nearly 660,000 cases expected in 2025, making it one of the top countries by total case count. Some countries are seeing explosive growth in cancer cases. Equatorial Guinea tops the list with a 50.5% increase in cases from 2022 to 2025. Kuwait follows with a 37% jump, and Syria with 26%. These aren't just about population growth – they reflect changing lifestyles, better detection, and aging populations. Cambodia shows a 20.7% increase in cases despite only 0.73% population growth, suggesting significant improvements in cancer detection or real increases in cancer incidence. Some small island nations punch above their weight in cancer statistics. New Caledonia (319.4), French Polynesia (250.7), and Samoa (241.6) all show elevated rates. Geographic isolation, genetic factors, and lifestyle changes might all play roles here. Eastern European countries show consistently high rates. Hungary (335.7), Croatia (324.9), and Latvia (303.4) are all in the top tier globally. Russia expects 635,621 cases in 2025 with an ASR of 251.9, making it one of the largest absolute numbers outside of China. The United States ranks fifth globally with an ASR of 381.1 and expects a massive 2.5 million new cancer cases in 2025 – a 6.5% increase from 2022. That's the second-highest total number globally, trailing only China. Canada shows similar patterns with 361.6 ASR and over 315,000 expected cases. African countries generally show lower rates, but there's huge variation. South Africa (213.6) has by far the continent's highest rate, more than double many of its neighbors. Countries like Niger (83.6), Congo (83.4), and Rwanda (82.9) cluster at the bottom of the global rankings. Middle Eastern countries present mixed pictures. Israel (244.5) and Lebanon (212.0) show higher rates, while Saudi Arabia (91.3), Oman (103.7), and Qatar (81.3) report much lower figures. The region's younger demographics and different risk factor profiles contribute to these variations. One fascinating pattern: cancer case increases often outpace population growth. Iran shows a 16.9% increase in cases with just 5.1% population growth. North Korea sees a 17.1% case increase with only 1.27% population growth. This pattern repeats across dozens of countries, suggesting that aging populations and changing lifestyles are driving cancer rates up faster than simple population growth would explain. When you zoom out and look at the global landscape, cancer rates form a clear pattern: wealthier, older populations in developed countries have the highest reported rates, while younger populations in developing nations show lower rates. But these numbers tell only part of the story. Detection capabilities, healthcare access, and data collection quality all influence what gets counted. The total global burden is immense – we're talking about tens of millions of new cancer cases worldwide in 2025. The countries with the largest absolute numbers are China, the United States, India, Germany, and Brazil. Together, these five nations account for a huge chunk of the world's cancer burden. These 2025 projections show us that cancer isn't slowing down. With populations aging globally and lifestyles changing rapidly in developing countries, we're likely to see these numbers continue climbing. The challenge for the coming years will be how different countries adapt their healthcare systems to handle this growing burden while also investing in prevention and early detection.Why Are Some Countries So High?
The Lowest Cancer Rate Countries
Asia's Interesting Split
Turkey's Position
Cancer Rates by Country 2025
#
1
482.4
462.5
228,202
212,332
3.41%
7.5%
2
431.1
427.3
41,891
38,157
8.42%
9.8%
3
385.7
374.7
51,515
48,840
2.29%
5.5%
4
381.1
367
2,535,766
2,380,189
2.63%
6.5%
5
379.8
357.9
43,203
40,305
0.78%
7.2%
6
363.3
344.7
33,802
31,242
2.01%
8.2%
7
361.6
345.9
315,177
292,098
2.72%
7.9%
8
353.4
339
499,651
483,568
-0.89%
3.3%
9
351
341.4
139,421
132,319
2.97%
5.4%
10
336.7
324.7
84,323
81,132
0.65%
3.9%
11
335.7
336.7
67,684
66,340
2.75%
2.0%
12
324.9
313.4
29,348
28,809
-2.34%
1.9%
13
320.1
307.8
471,780
454,954
-0.46%
3.7%
14
319.4
287.6
1,311
1,149
2.73%
14.1%
15
317
310
73,587
69,261
5.04%
6.2%
16
313.9
305.1
14,942
14,402
1.91%
3.7%
17
304.3
292.3
6,867
6,198
4.34%
10.8%
18
303.4
288.9
11,710
11,458
-3.14%
2.2%
19
301.9
292.7
60,971
58,330
1.49%
4.5%
20
299.2
294.6
71,064
69,567
0.57%
2.2%
21
297.7
284.5
444,265
436,242
-2.89%
1.8%
22
294
287.9
16,804
16,413
0.25%
2.4%
23
293.1
273.2
49,723
46,402
-0.21%
7.2%
24
289.4
279.9
17,150
16,817
-2.08%
2.0%
25
288.7
282.5
8,209
8,050
-0.53%
2.0%
26
288
276.9
39,162
37,660
-0.02%
4.0%
27
286.9
283.3
32,381
30,913
3.20%
4.7%
28
286.7
274.6
292,742
278,729
1.50%
5.0%
29
285.9
280.9
65,533
65,676
-2.11%
-0.2%
30
283.7
274.2
622,649
605,805
-0.82%
2.8%
31
283.4
273.3
3,765
3,440
4.01%
9.4%
32
281.8
267.1
1,042,544
1,005,157
-2.89%
3.7%
33
274.7
282.5
3,287
2,855
21.23%
15.1%
34
268.4
276.5
103,636
104,661
2.06%
-1.0%
35
268
258.5
52,508
50,682
-0.80%
3.6%
36
267.8
268.3
1,946
1,777
10.02%
9.5%
37
266
258.7
67,154
65,703
-0.52%
2.2%
38
260.6
250.4
36,438
42,039
-18.45%
-13.3%
39
258
253.9
2,135
2,123
-0.73%
0.6%
40
256.4
231.1
28,655
25,250
2.46%
13.5%
41
256
234.7
260,833
237,701
0.70%
9.7%
42
252.7
262.8
216,611
208,900
4.97%
3.7%
43
251.9
248.1
635,621
635,560
-1.59%
0.0%
44
250.7
228.1
1,085
877
10.44%
23.7%
45
246.7
235.8
7,548
6,699
4.73%
12.7%
46
245.7
238
2,823
2,739
-0.37%
3.1%
47
244.5
245.8
31,974
30,438
5.89%
5.0%
48
241.6
240
464
400
14.83%
16.0%
49
234.3
226.6
16,970
13,778
15.75%
23.2%
50
233.9
224.2
2,101
2,057
-2.21%
2.1%
51
232.7
225.9
250,486
240,013
1.33%
4.4%
52
229.5
232.2
11,665
14,816
-18.90%
-21.3%
53
226.7
215.8
141,457
133,420
0.71%
6.0%
54
226.7
220.8
50,595
49,688
-1.35%
1.8%
55
222
214.4
659,557
627,193
1.60%
5.2%
56
220.1
199.9
152,208
155,239
-10.26%
-2.0%
57
219.7
222
32,507
32,812
-4.08%
-0.9%
58
218.4
192.7
1,123
955
4.32%
17.6%
59
217.4
208
20,665
17,725
13.33%
16.6%
60
215.6
218.6
14,117
14,265
-2.08%
-1.0%
61
214.3
204.3
645
589
4.24%
9.5%
62
213.6
203.4
118,364
111,321
1.51%
6.3%
63
212.5
206.9
7,768
7,563
0.05%
2.7%
64
212
168.8
11,787
13,034
-23.74%
-9.6%
65
211.3
201.6
9,285
9,520
-6.56%
-2.5%
66
209.5
203.1
3,414
3,015
9.77%
13.2%
67
208.7
192.2
1,031
925
3.06%
11.5%
68
207.6
201.6
5,125,778
4,824,703
3.17%
6.2%
69
204
188.7
66,072
59,876
2.29%
10.3%
70
203.4
193.5
3,735
3,453
2.14%
8.2%
71
200.7
205.3
1,094
1,120
-1.89%
-2.3%
72
192.8
166.1
72,066
61,533
1.27%
17.1%
73
192.1
186.7
4,410
3,931
9.55%
12.2%
74
191.8
184.8
66,304
62,947
2.25%
5.3%
75
190.9
188.7
14,241
12,190
15.16%
16.8%
76
189.6
199.6
6,812
7,500
-5.42%
-9.2%
77
188.9
192.2
13,214
13,783
-3.76%
-4.1%
78
188.7
197.5
12,259
13,689
-6.53%
-10.4%
79
186.7
177.7
14,232
13,325
1.89%
6.8%
80
186.2
185.4
204,819
188,976
7.43%
8.4%
81
183.3
177.6
123,848
117,620
2.13%
5.3%
82
183
167.2
465
412
2.18%
12.9%
83
175.1
160.8
8,597
8,019
-1.56%
7.2%
84
174.5
174.8
1,670
1,601
4.46%
4.3%
85
173.8
169.5
1,228
1,119
6.27%
9.7%
86
171.7
154.4
208,546
183,541
2.68%
13.6%
87
170.5
167
21,443
20,171
4.30%
6.3%
88
167.5
173.8
73,088
72,827
3.95%
0.4%
89
166.4
138.3
23,884
19,795
0.73%
20.7%
90
166.1
149
160,356
137,198
5.10%
16.9%
91
166
166.1
164,646
150,578
9.53%
9.3%
92
162.7
150.8
196,047
180,480
1.16%
8.6%
93
162.2
162.3
37,785
36,225
4.43%
4.3%
94
161.4
152.6
14,397
12,328
11.08%
16.8%
95
161
166.8
415
448
-2.05%
-7.4%
96
160.7
149.1
49,356
44,726
1.97%
10.4%
97
160
154.5
10,064
9,101
4.78%
10.6%
98
159.7
152.3
5,551
5,030
5.15%
10.4%
99
159.5
159.5
21,647
19,846
9.18%
9.1%
100
159.2
152.3
19,720
18,503
2.03%
6.6%
101
159.2
154.9
8,922
8,353
3.14%
6.8%
102
159.2
159.5
17,070
15,296
11.49%
11.6%
103
158.8
152.7
33,003
30,888
2.48%
6.8%
104
154.8
149.8
65,946
63,609
2.11%
3.7%
105
153.3
140.9
222,470
207,154
-0.96%
7.4%
106
152.7
111.4
5,957
4,347
0.15%
37.0%
107
149.6
135.3
1,275
1,108
4.22%
15.1%
108
148.1
154.4
36,825
35,968
5.89%
2.4%
109
147.8
142.1
57,666
51,650
5.57%
11.6%
110
146.4
140.1
54,124
44,931
12.84%
20.5%
111
146
140
3,067
2,888
2.24%
6.2%
112
145.4
141.2
68,943
64,713
3.47%
6.5%
113
145.2
133.5
29,751
24,607
11.18%
20.9%
114
145.2
135.5
83,268
77,603
0.20%
7.3%
115
144
136.9
433,966
408,661
1.03%
6.2%
116
142.9
132.3
8,818
8,171
-0.03%
7.9%
117
140.2
136.6
43,809
37,382
12.77%
17.2%
118
138.3
135.4
22,322
20,551
5.14%
8.6%
119
135.1
113.8
1,488
1,383
-15.26%
7.6%
120
135.1
142.5
1,192
1,225
3.91%
-2.7%
121
135.1
134.8
739
684
7.20%
8.0%
122
133
105.3
579
479
-4.76%
20.9%
123
132.8
137
22,551
21,352
9.38%
5.6%
124
130.6
139.9
16,972
15,151
15.30%
12.0%
125
130.4
128.2
9,015
7,997
10.48%
12.7%
126
130.2
128.8
29,073
26,578
8.30%
9.4%
127
128.8
138.6
27,628
21,926
31.31%
26.0%
128
128.5
125.2
16,629
14,538
10.56%
14.4%
129
128.5
141.1
12,809
13,860
2.82%
-7.6%
130
128.2
122.7
7,665
6,807
7.66%
12.6%
131
127.3
126
21,428
19,564
8.02%
9.5%
132
126.9
107.7
1,394
926
19.97%
50.5%
133
125.7
133.5
8,568
8,409
6.76%
1.9%
134
125.1
120.4
31,258
27,385
9.40%
14.1%
135
124.9
116.3
10,245
8,777
7.27%
16.7%
136
124.7
106.8
697
619
-2.68%
12.6%
137
123.6
128
11,207
10,815
6.87%
3.6%
138
122.9
127.1
9,451
9,799
-1.89%
-3.6%
139
122.6
117.4
24,463
21,297
8.98%
14.9%
140
121.7
125.8
7,254
7,266
3.19%
-0.2%
141
121.5
121.8
17,803
17,801
0.28%
0.0%
142
121.3
114.4
2,180
1,875
8.64%
16.3%
143
120.3
143.8
15,338
17,579
6.28%
-12.7%
144
117.8
114.7
432
409
2.49%
5.6%
145
117.8
113.6
143,928
127,763
8.22%
12.7%
146
117.1
118.1
11,239
10,185
11.56%
10.3%
147
117.1
113.9
12,868
11,841
5.86%
8.7%
148
116.7
104.9
169
144
5.84%
17.4%
149
115.5
112.7
38,474
35,900
5.17%
7.2%
150
115.1
105.1
5,835
5,526
-4.13%
5.6%
151
114.7
115.2
4,121
3,873
6.64%
6.4%
152
114.2
115.4
2,602
2,317
13.20%
12.3%
153
113.8
121
11,677
10,681
14.49%
9.3%
154
111.9
107.5
6,359
5,491
9.10%
15.8%
155
110.8
105.6
184,655
167,256
5.08%
10.4%
156
108.9
106.9
34,482
33,243
1.97%
3.7%
157
106.8
115.5
2,042
2,027
9.45%
0.7%
158
106.1
108.2
267
250
8.82%
6.8%
159
105.1
104.5
89,155
80,334
10.04%
11.0%
160
104.7
100.3
1,331
1,170
8.77%
13.8%
161
103.7
105.3
3,755
4,045
-10.21%
-7.2%
162
103.3
98.5
1,532,538
1,413,316
3.41%
8.4%
163
101.7
99.8
2,665
2,463
6.21%
8.2%
164
101.4
105.3
3,326
3,274
4.61%
1.6%
165
101.4
105.6
195,492
185,748
8.92%
5.2%
166
101.2
106.2
25,255
24,275
9.23%
4.0%
167
100.8
102.6
8,343
7,496
13.06%
11.3%
168
100
99.4
6,833
6,874
-1.25%
-0.6%
169
99.2
103
58,053
52,612
14.53%
10.3%
170
94.9
91.7
7,145
6,467
5.62%
10.5%
171
93.2
87.6
686
638
1.19%
7.5%
172
92
95.6
30,306
28,586
10.05%
6.0%
173
91.9
87
507
435
7.49%
16.6%
174
91.3
87.1
31,209
28,113
5.98%
11.0%
175
90.9
101.8
2,878
2,690
21.54%
7.0%
176
90
90.7
919
805
14.98%
14.2%
177
89.1
84.5
902
828
2.17%
8.9%
178
83.6
83.7
12,999
11,593
12.39%
12.1%
179
83.4
80.7
3,098
2,727
10.11%
13.6%
180
82.9
83.2
7,694
7,122
8.36%
8.0%
181
82.4
81.6
23,191
22,008
4.47%
5.4%
182
81.3
82.4
1,673
1,733
-7.47%
-3.5%
183
80.1
83.1
18,845
16,525
15.55%
14.0%
184
77.7
79.2
1,431
1,196
13.79%
19.6%
185
38.3
35.9
2,277
1,918
10.34%
18.7%
Latin America's Numbers
The Dramatic Increases
Small Nations, Big Rates
Eastern Europe's Situation
The American Story
Africa's Mixed Picture
What About the Middle East?
Population Growth vs. Cancer Growth
Cancer Rates by Country 2025
The Big Picture
Looking Ahead
Frequently Asked Questions
Where does this cancer data come from and how is it calculated?
The 2025 cancer statistics are projections based on IARC (International Agency for Research on Cancer) 2022 reference data from iarc.fr. These aren't actual collected cases yet – they're estimates created by analyzing each country's population growth rates, demographic changes, and historical cancer trends between 2022 and 2025. Scientists use epidemiological modeling to make these projections, which helps health systems plan for future needs.
Why do wealthy countries have higher cancer rates than poor countries?
This seems counterintuitive, but it's mainly about three things: First, people in wealthier countries live longer, and cancer risk increases dramatically with age. Second, developed nations have sophisticated screening programs that detect many cancers that might go undiagnosed elsewhere. Third, better medical record systems mean more cases get officially counted. In contrast, many developing countries have younger populations, less comprehensive screening, and healthcare systems that may not diagnose or record all cancer cases. So lower rates don't necessarily mean better health – they often reflect different demographics and healthcare capabilities.
Data Disclaimer: Projected data (future years) are estimates based on mathematical models. Actual values may differ. Learn about our methodology →
Sources
-
Updated: 13.10.2025https://gco.iarc.fr/tomorrow/en/dataviz/tables
Please log in to leave a comment.
Log in
(0) Comments